Clinical characteristics and risk factors of arrhythmia during follow‐up of patients with idiopathic ventricular fibrillation

2020 ◽  
Vol 31 (10) ◽  
pp. 2677-2686
Author(s):  
Niels K. Stampe ◽  
Camilla B. Jespersen ◽  
Charlotte Glinge ◽  
Henning Bundgaard ◽  
Jacob Tfelt‐Hansen ◽  
...  
Keyword(s):  
Risk Factors ◽  
Ventricular Fibrillation ◽  
Clinical Characteristics ◽  
Idiopathic Ventricular Fibrillation

CLINICAL CHARACTERISTICS OF PATIENTS WITH IDIOPATHIC VENTRICULAR FIBRILLATION

2005 ◽  
Author(s):  
HIDEO OKAMURA ◽  
SHIRO KAMAKURA ◽  
TAKASHI NODA ◽  
KIYOSHI OTOMO ◽  
KAZUHIRO SATOMI ◽  
...  
Keyword(s):  
Ventricular Fibrillation ◽  
Clinical Characteristics ◽  
Idiopathic Ventricular Fibrillation

Idiopathic ventricular fibrillation in two infants, not always idiopathic on follow-up

Heart Rhythm ◽  
2009 ◽  
Vol 6 (10) ◽  
pp. 1501-1503 ◽  
Author(s):  
Priya Chockalingam ◽  
Sally-Ann B. Clur ◽  
Annette G. Reimer ◽  
Nico A. Blom ◽  
Arthur A. Wilde
Keyword(s):  
Ventricular Fibrillation ◽  
Idiopathic Ventricular Fibrillation

scholarly journals Clinical characteristics of progressive nonarteritic anterior ischemic optic neuropathy

2021 ◽  
Vol 14 (4) ◽  
pp. 517-522
Author(s):  
Omer Y. Bialer ◽  
Keyword(s):  
Risk Factors ◽  
Visual Acuity ◽  
Color Vision ◽  
Symptom Onset ◽  
Systemic Risk ◽  
Clinical Characteristics ◽  
Visual Outcome ◽  
Ischemic Optic Neuropathy ◽  
Systemic Risk Factors

AIM: To study whether patients with progressive nonarteritic anterior ischemic optic neuropathy (NAION) present earlier than patients with stable NAION and to describe their clinical characteristics and visual outcome. METHODS: This was a retrospective chart review. All patients with NAION seen during the acute stage from January 2012 to December 2018 were reviewed. Patients were included if they had documented disc edema and follow up of at least 3mo. Patients with progressive NAION were identified if they worsened in 2 out of 3 parameters: visual acuity ≥3 Snellen lines; Color vision ≥4 Ishihara plates; the visual field defect involved a new quadrant. The clinical characteristics, time from symptom onset to presentation, systemic risk factors and visual outcome were compared to patients with stable NAION. RESULTS: Totally 122 NAION cases met the inclusion criteria. Mean age was 58.1y (range 22-74), 70% were men. Twenty cases (16.4%) had progressive NAION. Patients with progressive NAION did not differ from stable NAION in their demographics, systemic risk factors or in their initial visual deficit. At last follow up, median visual acuity was 1.0 logMAR (IQR 0.64-1.55) in patients with progressive NAION, vs 0.18 (IQR 0.1-0.63) in stable NAION (P<0.001). Median color vision testing was 0 plates correct (IQR 0-2.5%) vs 92% plates correct (IQR 50%-100%) in the stable NAION group (P<0.001). Patients with progressive NAION differed in the time from symptom onset to presentation (median 2d vs 5d, P=0.011). CONCLUSION: We find no identifiable risk factors associated with progressive NAION. Progressors arrive earlier for ophthalmological evaluation.

scholarly journals Prevalence, risk factors and clinical characteristics of renal dysfunction in Chinese outpatients with growth simple renal cysts

2021 ◽  
Author(s):  
Qiaoru Wu ◽  
Chunhua Ju ◽  
Miaowen Deng ◽  
Xiaolong Liu ◽  
Zhongda Jin
Keyword(s):  
Risk Factors ◽  
Renal Dysfunction ◽  
Clinical Characteristics ◽  
Renal Cysts ◽  
Maximum Diameter ◽  
Large Sample Size ◽  
Female Total ◽  
Long Term Follow Up ◽  
Yearly Change

Abstract Background Researchers have proved that simple renal cysts (SRCs) might be correlated with renal dysfunction, but it is still controversial. Thus, we conducted clinical research study with large sample size and long-term follow-up to clarify the relationship between SRCs and renal dysfunction. Methods A total of 571 SRCs patients in outpatients of nephrology department were included, we investigated the clinical characteristics of growth SRCs compared with non-growth SRCs, evaluated the incidence of renal dysfunction in SRCs and explored the risk factors of renal dysfunction in growth SRCs. Results The mean baseline age was 51.31 ± 14.37 years in the whole cohort, ranging from 19 to 79 years, and 57.6% of them were male. The median follow-up duration was 3 years, ranging from 1 to 10 years. In addition, the final maximum diameter increased 1 mm (2.74%) per year. Patients in growth SRCs group tented to have higher percentage of hypertension, hematuria, large cyst and multiple cysts compared with non-growth SRCs group. The prevalence of renal dysfunction was 15.6% after the follow-up, and the prevalence of renal dysfunction was about 10 times higher in growth SRCs group than non-growth SRCs group (23.3% vs. 2.4%). Renal dysfunction was significantly associated with age, female, total cholesterol, diastolic blood pressure, final maximum diameter and yearly change in maximum diameter in growth SRCs. Conclusions SRCs were closely related to the decline of renal function, we recommend close follow-up for growth SRCs.

Incidence and predictors of implantable cardioverter-defibrillator therapy and its complications in idiopathic ventricular fibrillation patients

EP Europace ◽  
2019 ◽  
Vol 21 (10) ◽  
pp. 1519-1526
Author(s):  
Lennart J Blom ◽  
Marloes Visser ◽  
Imke Christiaans ◽  
Marcoen F Scholten ◽  
Marianne Bootsma ◽  
...  
Keyword(s):  
Cardiac Arrest ◽  
Ventricular Fibrillation ◽  
Implantable Cardioverter Defibrillator ◽  
Recurrent Events ◽  
Risk Haplotype ◽  
Implantable Cardioverter Defibrillator Therapy ◽  
Idiopathic Ventricular Fibrillation ◽  
Icd Therapy ◽  
Cardioverter Defibrillator

Abstract Aims Idiopathic ventricular fibrillation (IVF) is a rare cause of sudden cardiac arrest. Implantable cardioverter-defibrillator (ICD) implantation is currently the only treatment option. Limited data are available on the prevalence and complications of ICD therapy in these patients. We sought to investigate ICD therapy and its complications in patients with IVF. Methods and results Patients were selected from a national registry of IVF patients. Patients in whom no underlying diagnosis was found during follow-up were eligible for inclusion. Recurrence of ventricular arrhythmia (VA) was derived from medical and ICD records, electrogram records of ICD therapies were used to differentiate between appropriate or inappropriate interventions. Independent predictors for appropriate ICD shock were calculated using cox regression. In 217 IVF patients, recurrence of sustained VAs occurred in 66 patients (30%) during a median follow-up period of 6.1 years. Ten patients died (4.6%). Thirty-eight patients (17.5%) experienced inappropriate ICD therapy, and 32 patients (14.7%) had device-related complications. Symptoms before cardiac arrest [hazard ratio (HR): 2.51, 95% confidence interval (CI): 1.48–4.24], signs of conduction disease (HR: 2.27, 95% CI: 1.15–4.47), and carrier of the DPP6 risk haplotype (HR: 3.24, 1.70–6.17) were identified as independent predictors of appropriate shock occurrence. Conclusion Implantable cardioverter-defibrillator therapy is an effective treatment in IVF, treating recurrences of potentially lethal VAs in approximately one-third of patients during long-term follow-up. However, device-related complications and inappropriate shocks were also frequent. We found significant predictors for appropriate ICD therapy. This may imply that these patients require additional management to prevent recurrent events.

Sign in / Sign up

Export Citation Format

Share Document